Showing 61-70 of 3305 results for "".
Vitiligo: Current and Future Developments
https://practicaldermatology.com/conferences/maui-derm-2020/vitiligo-current-and-future-developments/19722/John E. Harris, MD, PhD reviews treatment advances and emerging science in vitiligo. From new topical agents to intriguing studies on a potential role for biologics, there is very good reason to be optimistic about the future of vitiligo treatment.The Latest in Hidradenitis Suppurativa (HS)
https://practicaldermatology.com/conferences/maui-derm-2024/the-latest-in-hidradenitis-suppurativa-hs/20251/Raj Chovatiya, MD, PhD, board-certified dermatologist and clinician investigator based in Chicago, discusses the incredible pipeline for Hidradenitis suppurativa (HS), as well as new and emerging treatment options.Winning Combinations in Scar Revision
https://practicaldermatology.com/conferences/asds-2021/winning-combinations-in-scar-revision/20028/Sherrif F. Ibrahim, MD, PhD says a combination approach is often best when it comes to laser scar revision. He discusses the devices he uses to improve the color and texture of scars to meet his patients' needs.Clinical Data on Switching to Upadacitinib
https://practicaldermatology.com/videos/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.Chronic Hand Eczema Treatment Landscape
https://practicaldermatology.com/videos/c-suite-chats/chronic-hand-eczema-treatment-landscape/29126/Jacob Thyssen, MD, PhD, Chief Scientific Officer at Leo Pharma, talks about the incidence of chronic hand eczema and the advantage that delgocitinib provides compared to other treatment options.Seborrheic Dermatitis Approaches and Stopping Biologic Treatment for Atopic Dermatitis
https://practicaldermatology.com/conferences/scale-2025/seborrheic-dermatitis-approaches-and-stopping-biologic-treatment-for-atopic-dermatitis/35896/Naiem T. Issa, MD, PhD, talks at Music City SCALE 2025 about how to approach seborrheic dermatitis, as well as what happens to atopic dermatitis patients after ending biologic treatments.DERM2020 Content Recap: Adam Friedman, MD
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-adam-friedman/19839/DERM2020 Faculty Adam Friedman, MD shares his thoughts on DERM2020 and some of his content.DERM2020 Content Recap: Julie Harper, MD
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-julie-harper-md/19844/DERM20920 Faculty Julie Harper, MD discusses what’s new in rosacea from her presentation during DERM2020.DERM2020 Content Recap: Linda Stein Gold, MD
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-linda-stein-gold-md/19845/DERM2020 Faculty Linda Stein Gold, MD discusses what’s new in acne from her presentation during DERM2020.New Thinking: Eczema as a Systemic Disease
https://practicaldermatology.com/topics/psoriasis/new-thinking-eczema-as-a-systemic-disease/18756/By Seemal R. Desai, MD and Emma Guttman, MD, PhD, FAADEczema is an immune-driven disease like psoriasis. How is that knowledge changing the way that dermatologists treat patients? Are similar changes taking place for other inflammatory diseases? Dr. Guttman talks about the latest.